"Tryptamines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Decarboxylated monoamine derivatives of TRYPTOPHAN.
| Descriptor ID |
D014363
|
| MeSH Number(s) |
D02.092.211.215.801 D03.633.100.473.914
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Tryptamines".
Below are MeSH descriptors whose meaning is more specific than "Tryptamines".
This graph shows the total number of publications written about "Tryptamines" by people in this website by year, and whether "Tryptamines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2010 | 1 | 1 | 2 |
| 2013 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2017 | 1 | 1 | 2 |
| 2018 | 2 | 1 | 3 |
| 2019 | 3 | 2 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Tryptamines" by people in Profiles.
-
Gekko gecko extract attenuates airway inflammation and mucus hypersecretion in a murine model of ovalbumin-induced asthma. J Ethnopharmacol. 2022 Jan 10; 282:114574.
-
A real-world study on unmet medical needs in triptan-treated migraine: prevalence, preventive therapies and triptan use modification from a large Italian population along two years. J Headache Pain. 2019 Jun 27; 20(1):74.
-
Gepants for the treatment of migraine. Expert Opin Investig Drugs. 2019 06; 28(6):555-567.
-
Optimising migraine treatment: from drug-drug interactions to personalized medicine. J Headache Pain. 2019 May 17; 20(1):56.
-
Almotriptan: a review of 20 years' clinical experience. Expert Rev Neurother. 2019 08; 19(8):759-768.
-
Patterns of initial migraine treatment in Denmark: A population-based study. Pharmacoepidemiol Drug Saf. 2019 03; 28(3):322-329.
-
Advances in orally administered pharmacotherapy for the treatment of migraine. Expert Opin Pharmacother. 2019 02; 20(2):209-218.
-
Novel cinnamic acid-tryptamine hybrids as potent butyrylcholinesterase inhibitors: Synthesis, biological evaluation, and docking study. Arch Pharm (Weinheim). 2018 Oct; 351(10):e1800115.
-
May migraine attack response to triptans be a predictor of the efficacy of Onabotulinum toxin-A prophylaxis? Neurol Sci. 2018 Jun; 39(Suppl 1):153-154.
-
Menstrual migraine: a review of current and developing pharmacotherapies for women. Expert Opin Pharmacother. 2018 02; 19(2):123-136.